Evidence map›Paper›PMID 42564115›Full record

ArticleFrontiers in oncology2026

Radiomics-based high-resolution CT analysis for differentiating primary tumor sources of pulmonary metastases.

Kangning Liu, Yingnan Zhang, Xiaoxuan Xie, Na Li, Genyun Liu, Weijia Li, Yuhang Wu, Bowen Hu, Fei Zhao, Zhiling Wan and 3 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Kangning Liu *Xuzhou Medical University, Xuzhou, Jiangsu, China.
Yingnan Zhang *The Affiliated Xuzhou Municipal Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Xiaoxuan Xie *Xuzhou Central Hospital Affiliated to Medical School of Southeast University, Xuzhou, Jiangsu, China.
Na LiXuzhou Central Hospital Affiliated to Medical School of Southeast University, Xuzhou, Jiangsu, China.
Genyun LiuXuzhou Central Hospital Affiliated to Medical School of Southeast University, Xuzhou, Jiangsu, China.
Weijia LiXuzhou Medical University, Xuzhou, Jiangsu, China.
Yuhang WuXuzhou Clinical School of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Bowen HuXuzhou Central Hospital Affiliated to Medical School of Southeast University, Xuzhou, Jiangsu, China.
Fei ZhaoThe Affiliated Xuzhou Municipal Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Zhiling WanThe Affiliated Xuzhou Municipal Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Yifan ZhangXuzhou Central Hospital Affiliated to Medical School of Southeast University, Xuzhou, Jiangsu, China.
Yun ZhouXuzhou Central Hospital Affiliated to Medical School of Southeast University, Xuzhou, Jiangsu, China.
Xiaojin WuXuzhou Clinical School of Xuzhou Medical University, Xuzhou, Jiangsu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To evaluate machine learning models based on HRCT radiomic features for distinguishing breast and colorectal cancer pulmonary metastases, and interpret the optimal model to aid clinical decision-making. Methods: This retrospective study enrolled 85 patients with pathologically confirmed pulmonary metastases. After radiomic feature extraction, the cohort was divided into a training set (n=59) and an independent test set (n=26) at a 7:3 ratio via stratified sampling. Data were processed with Z-score normalization, variance thresholding and PCA (45 principal components). Five classifiers were constructed: LR, linear SVM, RF, XGBoost and LightGBM. Model stability and performance were assessed by 5-fold stratified cross-validation and independent test validation. Results: The 45 principal components accounted for 99.92% of cumulative variance. LR showed optimal performance, with a test AUC of 0.9821, classification accuracy of 84.62%, and a mean cross-validation AUC of 0.9606 (95% CI: 0.8887-0.9895). The small training-test AUC difference (0.0179) indicated no severe overfitting. SVM ranked second (test AUC = 0.9405), while XGBoost and RF exhibited significant overfitting and LightGBM underfitting. The model's decision relied on key texture features; only GLSZM non-uniformity differed significantly between groups, consistent with their pathophysiological characteristics. Conclusion: The PCA-reduced and regularization-optimized LR model has excellent generalization, stability and clinical interpretability in differentiating pulmonary metastases from breast and colorectal cancers. This study preliminarily highlights the potential of LR in high-dimensional small-sample scenarios, and provides a foundational methodological reference for future large-scale multicenter diagnostic research.

Indexed as

high-resolution CTlogistic regressionmachine learningpulmonary metastasesradiomics

Identifiers

PMID42564115
PMCPMC13442393

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.